Schizophrenia Research is a premier academic journal focused on innovative research within the domain of psychiatry and mental health, published by Elsevier. With its ISSN 0920-9964 and E-ISSN 1573-2509, the journal has established a strong presence since its inception in 1988, evolving to publish cutting-edge findings up to 2024. Positioned in Q1 in Psychiatry and Mental Health and Q2 in Biological Psychiatry, it ranks impressively in the 83rd percentile among its peers, according to Scopus, ranking #93/567 in the field of Medicine, and #12/51 in Neuroscience. This journal serves as a vital platform for the dissemination of significant scientific advancements and theoretical insights into schizophrenia, fostering a deeper understanding of mental illnesses. Although it operates on a subscription basis, its critical role in informing both ongoing research and clinical practices cannot be overstated, making it an essential resource for researchers, clinicians, and students alike. Join a global community dedicated to improving mental health outcomes and advancing the study of schizophrenia through this reputable publication.

European Archives of Psychiatry and Clinical Neuroscience is a prominent peer-reviewed journal published by Springer Heidelberg, focusing on the interdisciplinary aspects of psychiatry and clinical neuroscience. With an ISSN of 0940-1334 and an E-ISSN of 1433-8491, this journal provides a rigorous platform for innovative research spanning biological psychiatry, pharmacology, and various aspects of mental health. The journal boasts a distinguished impact factor that places it in the Q2 category for Biological Psychiatry and Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health as of 2023, reflecting its significant contribution to the field. Additionally, its Scopus rankings highlight its esteemed position among the top journals, particularly in Medicine and Neuroscience disciplines. Readers can access a wealth of valuable research articles, case studies, and reviews, crucial for advancing understanding and treatment within these vital fields. Initially converged in 1990, the journal continues to evolve and support scholarly dialogue until 2024 and beyond, making it an essential resource for researchers, clinicians, and students alike.

BJPsych Open, published by Cambridge University Press, is a leading open access journal dedicated to the field of psychiatry and mental health. Since its inception in 2015, the journal has provided a platform for disseminating cutting-edge research and evidence-based practices, making significant contributions to the academic community. With an impressive impact factor and currently ranking in the top Q1 quartile of its field, BJPsych Open is recognized for its rigor and relevance, ranking 138 out of 567 journals in psychiatry and mental health according to Scopus, placing it in the 75th percentile. The journal's commitment to open access enhances visibility and accessibility, ensuring that vital research is available to a global audience. Researchers, professionals, and students alike will find valuable insights into contemporary mental health challenges and innovative treatment approaches, making BJPsych Open an essential resource for advancing mental health scholarship.

Brain Communications is an esteemed, open-access academic journal published by Oxford University Press since 2019, focusing on the dynamic field of neuroscience. With a dedicated ISSN and an E-ISSN of 2632-1297, this journal aims to address the intricate relationships between brain functions, psychiatric disorders, and neurobiological mechanisms. The journal stands out in the academic realm, holding a prestigious Q1 ranking across several categories, including Biological Psychiatry, Cellular and Molecular Neuroscience, Neurology, and Psychiatry and Mental Health for 2023. Notably, it has also secured impressive Scopus ranks in various neuroscience and psychiatry fields, evidencing its commitment to high-quality research. With an impact factor reflective of its growing influence, Brain Communications provides accessible research findings to professionals, researchers, and students alike, fostering a deeper understanding of complex neurological phenomena. This innovative journal is pivotal for anyone involved in advancing knowledge in neuroscience and mental health.

Cognitive Neurodynamics is a leading journal in the field of cognitive neuroscience, published by Springer in the Netherlands. With an ISSN of 1871-4080 and an E-ISSN of 1871-4099, this journal has established itself as a prominent platform for innovative research from its inception in 2007, continuing to enrich the academic landscape through 2024. Recognized for its significant contributions, Cognitive Neurodynamics holds a Q2 quartile ranking in cognitive neuroscience and impressively ranks #27 out of 115 in the Scopus database, placing it in the 76th percentile among its peers. While the journal is not open access, it offers a wealth of studies focusing on the intricate dynamics of cognitive processes and neurobiological mechanisms, making it essential reading for researchers, professionals, and students alike. Its objective is to bridge the gap between theoretical insights and practical applications, fostering a deeper understanding of cognition through multidisciplinary approaches. Explore the latest advancements in cognitive dynamics and contribute to the evolving dialogue within this fascinating field.

Cognitive Neuropsychiatry is a distinguished academic journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to the intersection of cognitive neuroscience and psychiatry. With a strong commitment to advancing knowledge in these rapidly evolving fields, this journal provides a platform for high-quality, peer-reviewed research that explores cognitive processes underlying psychiatric disorders. Aiming to bridge gaps between neuroscience and clinical practice, it serves as an essential resource for researchers, professionals, and students alike. As evidenced by its performance metrics, the journal ranks in the Q2 quartile for Psychiatry and Mental Health, and Q3 for Cognitive Neuroscience, showcasing its relevance and growing impact, particularly among a competitive audience. While it does not currently offer open access options, Cognitive Neuropsychiatry remains a vital outlet for disseminating impactful findings, offering insights that shape contemporary psychiatric understanding and interventions.

SCHIZOPHRENIA BULLETIN, published by Oxford University Press, stands as a leading journal in the field of psychiatry and mental health, particularly focusing on the complexities of schizophrenia. Established in 1973, this esteemed journal covers a wide spectrum of research areas, including clinical findings, neurobiology, epidemiology, and treatment approaches, making it indispensable for researchers and practitioners alike. With its current status in the Q1 category of the psychiatry and mental health disciplines, and a remarkable Scopus rank of #34 out of 567, the journal enjoys a strong impact factor, emphasizing its contribution to advancing knowledge in mental health. Although it operates on a subscription model, the significance of the journal in disseminating groundbreaking research makes it a vital resource for those committed to improving outcomes in schizophrenia. Through its rigorous peer-review process and commitment to high-quality scientific communication, SCHIZOPHRENIA BULLETIN continues to be at the forefront of psychiatric research and discourse.

Schizophrenia Research-Cognition is an esteemed journal dedicated to advancing the understanding of cognitive aspects of schizophrenia and related mental health disorders. Published by Elsevier, this Open Access journal has been a pivotal platform since its inception in 2014, facilitating the dissemination of high-quality research findings to a global audience. With a notable impact factor and categorized in the Q2 quartile for both Cognitive Neuroscience and Psychiatry and Mental Health, it ranks among the top journals in these fields, currently positioned at #171 out of 567 in Psychiatry and at #40 out of 115 in Cognitive Neuroscience according to Scopus metrics. Located in the United States, and published under the auspices of Elsevier, the journal aims to provide an insightful forum for researchers, clinicians, and students interested in the cognitive underpinnings of schizophrenia, promoting innovative research that bridges the gap between cognitive neuroscience and clinical application. Schizophrenia Research-Cognition's commitment to open access ensures wide-reaching impact and engagement from the research community and beyond.

BEHAVIOURAL BRAIN RESEARCH, published by Elsevier, is a leading scholarly journal that has been at the forefront of research in Behavioral Neuroscience since its inception in 1980. With an ISSN of 0166-4328 and an e-ISSN of 1872-7549, this journal caters to a global audience of researchers and professionals keen on exploring the intricate relationships between behavior and neural processes. As of 2023, it holds an impressive Q2 ranking within its category, showcasing its significant impact with a Scopus rank of #28 out of 88 in the field, placing it in the 68th percentile. While the journal does not offer open access, it remains accessible through institutional subscriptions, ensuring that its high-quality research is disseminated effectively. The journal's commitment to advancing knowledge in behavioral neuroscience makes it an indispensable resource for those looking to delve deep into the complexities of brain-behavior interactions and foster innovative approaches in both research and clinical applications.

Schizophrenia, published by NATURE PORTFOLIO, is a pioneering open-access journal established in 2022, dedicated to advancing the scientific understanding of schizophrenia and its associated disorders. With its commitment to disseminating high-quality research without barriers, this journal aims to provide a platform for innovative studies, reviews, and meta-analyses that enhance clinical practices and therapeutic approaches. The journal is strategically located in Berlin, Germany, a hub for mental health research and innovation. By facilitating open exchange among researchers, professionals, and students, Schizophrenia aspires to be at the forefront of the global discourse on psychiatric disorders, driving forward critical advancements that can translate into improved patient care and outcomes. With a focus on promoting the latest findings in epidemiology, neurobiology, pharmacology, and psychosocial interventions, this journal is poised to become an essential resource for scholars and practitioners alike, eager to make significant contributions to the field.